Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Clinical trial NCT04142437 · RECRUITING

Trial details

NCT number: NCT04142437
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Start date: 2020-04-03
Primary completion: 2029-11-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.